✽ Cúram, a government-funded centre for medical device research, has signed a collaboration agreement with start-up Arch Therapeutics.
Under the terms of the deal, Cúram will give Arch Therapeutics grant-funding for personnel and infrastructure.
Arch is developing a device to stem blood loss during surgery and trauma care. The company is using a self-assembling peptide technology platform to develop a surgical hemostatic device called AC5.
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team